Eli Lilly CEO Dave Ricks says company is capturing 70% of seniors starting GLP-1 drugs

Eli Lilly CEO Dave Ricks said the company is capturing 70% of seniors who start GLP-1 drugs, a claim on the company's share of the fast-growing weight-loss and diabetes market.

Detected & updated continuously · Source: Nebula